Inventor
Rui Xu
Inventor
Boulder, CO, US
Overview
Patents· 32 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
A61KPreparations for medical, dental or toiletry purposes16%
C07CAcyclic or carbocyclic compounds7%
C07BGeneral methods of organic chemistry5%
B41MPrinting, duplicating, marking, or copying processes1%
B44FSpecial designs or pictures1%
G09FDisplaying1%
Y10TTechnical subjects covered by former us classification1%
PatentTitleYear
10,807,948Aromatic compounds and uses thereof202010,597,366Aryl ethers and uses thereof202010,155,726Substituted pyridines and uses thereof201810,144,711Aryl ethers and uses thereof20189,969,689Aryl ethers and uses thereof20189,908,845'Aryl ethers and uses thereof'20189,896,418'Aryl ethers and uses thereof'20189,884,843'Cyclic sulfone and sulfoximine analogs and uses thereof'20189,546,156'N-bicyclic aryl,N\'-pyrazolyl urea, thiourea, guanidine cyanoguanidine compounds as TrkA kinase inhibitors'20179,409,886'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20169,359,340'Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors'20169,346,805'Pyrimidyl cyclopentanes as Akt protein kinase inhibitors'20169,328,091'5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors'20169,303,040'Substituted piperazines as AKT inhibitors'20168,895,566'5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors'20148,889,704'Triazolopyridine compounds as PIM kinase inhibitors'20148,865,726'Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors'20148,853,199'Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20148,853,216'Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor'20148,846,683'Pyrimidyl cyclopentanes as Akt protein kinase inhibitors'20148,846,681'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20148,835,434'Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors'20148,680,114'AKT protein kinase inhibitors'20148,618,097'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20138,377,937'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20138,329,709'5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors'20128,329,701'Dihydrofuro pyrimidines as AKT protein kinase inhibitors'20128,324,221'Pyrimidyl cyclopentanes as Akt protein kinase inhibitors'20128,063,050'Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20118,003,651'Pyrimidyl cyclopentanes as AKT protein kinase inhibitors'20117,091,357'Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies'20066,503,922'Bridged nicotine compounds for use in the treatment of CNS pathologies'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003Based in New York, NY, US· patent location history
2006–2016Based in Longmont, CO, US· patent location history
2011–2017Patents assigned to ARRAY BIOPHARMA INC (22)· patent assignee history
2011–2016Patents assigned to GENENTECH INC (14)· patent assignee history
2011–2016Patents assigned to XU RUI (14)· patent assignee history
2011–2016Patents assigned to MITCHELL IAN S (12)· patent assignee history
2011–2016Patents assigned to BLAKE JAMES F (11)· patent assignee history
2012–2016Based in Boulder, CO, US· patent location history
2017–2020Based in Dallas, TX, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARRAY BIOPHARMA INC | 22 | 2011–2017 |
| GENENTECH INC | 14 | 2011–2016 |
| XU RUIself | 14 | 2011–2016 |
| MITCHELL IAN S | 12 | 2011–2016 |
| BLAKE JAMES F | 11 | 2011–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boulder, CO, US | 12 | 2012–2016 |
| Longmont, CO, US | 10 | 2006–2016 |
| Dallas, Texas, US | 9 | 2017–2020 |
| New York, New York, US | 1 | 2003 |